MD2Me - Texting to Promote Chronic Disease Management
- Conditions
- Chronic Disease ManagementType 1 DiabetesInflammatory Bowel DiseaseCystic Fibrosis
- Interventions
- Behavioral: MD2ME
- Registration Number
- NCT01253733
- Lead Sponsor
- Huang, Jeannie, M.D.
- Brief Summary
UCSD researchers are conducting a study aimed to develop and evaluate a chronic disease self management web and text message based program on health-related self-efficacy and frequency of adolescent-conducted healthcare interactions. We hypothesize that users of the program will demonstrate greater gains between baseline and 8 month measures of health related self-efficacy and adolescent-conducted healthcare interactions as compared to the usual care comparison group.
- Detailed Description
The MD2Me study (or also known as TAHLC), sponsored by the National Institutes of Health is a 2-year randomized controlled trial to develop and test a text message and Internet based intervention among adolescents and young adults with cystic fibrosis, type 1 diabetes, or inflammatory bowel disease. Adolescents and young adults have been a difficult population to engage in healthcare. It is estimated that 1 in 5 adolescents do not get the healthcare they need. Interventions must address how the healthcare system can engage adolescents with chronic disease and provide opportunities to discuss health-related matters and improve disease outcomes.
This study will help fill multiple gaps in the literature by exploring the utility of a push AND pull SMS texting-based application for chronic disease management among youth. Based on social cognitive theory, the intervention will use accessible technology to promote disease management among adolescents with chronic disease as they transition to adult care. The popularity and usage of SMS already demonstrated by adolescents suggests notable promise for the SMS-based TAHLC program to promote chronic disease self-management and healthcare engagement with substantial positive impacts on health among youth with chronic disease.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 81
- ages 14 - 22 years
- have cystic fibrosis, type 1 diabetes, or inflammatory bowel disease for at least 6 months
- have access to the internet
- speak English
- has a parent that speaks English or Spanish (if primary participant is under 18)
- willingness to attend assessment visits
- pregnant or have children
- have a history of substance abuse or other psychiatric disorder that would impair compliance with study protocol
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description SMS and Internet MD2ME The SMS and Internet group will receive information, tips, strategies, and questions related to the self management of chronic disease (cystic fibrosis, inflammatory bowel disease, or type 1 diabetes) on a web-based program and via SMS messages.
- Primary Outcome Measures
Name Time Method Health related self-efficacy 8 months The primary aim of the study will be to develop and test the effect of a texting intervention TAHLC on health-related self-efficacy and frequency of adolescent-conducted healthcare interactions over the study period of 8 months.
- Secondary Outcome Measures
Name Time Method Health knowledge 8 months Disease health knowledge
Health literacy 8 months Health literacy
Quality of Life 8 Months Quality of life including depression, self-esteem, and social support will be assessed.
Trial Locations
- Locations (1)
University of California, San Diego
🇺🇸La Jolla, California, United States